Free Trial

Envoy Medical (COCH) Competitors

Envoy Medical logo
$1.48 +0.02 (+1.37%)
Closing price 04/25/2025 03:57 PM Eastern
Extended Trading
$1.66 +0.18 (+12.16%)
As of 04/25/2025 05:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

COCH vs. LUCD, OBIO, AVR, INFU, KRMD, SKIN, MGRM, ICAD, NSPR, and MBOT

Should you be buying Envoy Medical stock or one of its competitors? The main competitors of Envoy Medical include Lucid Diagnostics (LUCD), Orchestra BioMed (OBIO), Anteris Technologies Global (AVR), InfuSystem (INFU), KORU Medical Systems (KRMD), Beauty Health (SKIN), Monogram Orthopaedics (MGRM), iCAD (ICAD), InspireMD (NSPR), and Microbot Medical (MBOT). These companies are all part of the "medical equipment" industry.

Envoy Medical vs.

Envoy Medical (NASDAQ:COCH) and Lucid Diagnostics (NASDAQ:LUCD) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, community ranking, media sentiment, institutional ownership and valuation.

Envoy Medical currently has a consensus price target of $9.13, indicating a potential upside of 516.55%. Lucid Diagnostics has a consensus price target of $3.50, indicating a potential upside of 163.16%. Given Envoy Medical's higher possible upside, analysts clearly believe Envoy Medical is more favorable than Lucid Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envoy Medical
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Lucid Diagnostics
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20

In the previous week, Envoy Medical had 9 more articles in the media than Lucid Diagnostics. MarketBeat recorded 18 mentions for Envoy Medical and 9 mentions for Lucid Diagnostics. Envoy Medical's average media sentiment score of 0.62 beat Lucid Diagnostics' score of 0.59 indicating that Envoy Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Envoy Medical
1 Very Positive mention(s)
0 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Lucid Diagnostics
3 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

Lucid Diagnostics has a net margin of -1,069.87% compared to Envoy Medical's net margin of -7,607.55%.

Company Net Margins Return on Equity Return on Assets
Envoy Medical-7,607.55% N/A -262.28%
Lucid Diagnostics -1,069.87%N/A -123.54%

Envoy Medical has a beta of 2.35, meaning that its stock price is 135% more volatile than the S&P 500. Comparatively, Lucid Diagnostics has a beta of 1.26, meaning that its stock price is 26% more volatile than the S&P 500.

Lucid Diagnostics received 32 more outperform votes than Envoy Medical when rated by MarketBeat users. However, 100.00% of users gave Envoy Medical an outperform vote while only 68.97% of users gave Lucid Diagnostics an outperform vote.

CompanyUnderperformOutperform
Envoy MedicalOutperform Votes
8
100.00%
Underperform Votes
No Votes
Lucid DiagnosticsOutperform Votes
40
68.97%
Underperform Votes
18
31.03%

Envoy Medical has higher earnings, but lower revenue than Lucid Diagnostics. Lucid Diagnostics is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envoy Medical$225K140.28-$29.91M-$1.41-1.05
Lucid Diagnostics$4.35M32.25-$52.67M-$1.08-1.23

8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 74.0% of Lucid Diagnostics shares are owned by institutional investors. 60.5% of Envoy Medical shares are owned by company insiders. Comparatively, 8.8% of Lucid Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Envoy Medical and Lucid Diagnostics tied by winning 9 of the 18 factors compared between the two stocks.

Get Envoy Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for COCH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COCH vs. The Competition

MetricEnvoy MedicalSurgical appliances & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$31.56M$9.08B$5.46B$7.81B
Dividend YieldN/A1.67%5.43%4.26%
P/E Ratio-1.0519.3322.4318.48
Price / Sales140.2873.96391.42101.49
Price / CashN/A19.6738.1834.62
Price / Book-16.444.916.684.19
Net Income-$29.91M$284.66M$3.22B$248.18M
7 Day Performance10.45%7.21%6.25%6.54%
1 Month Performance6.86%-1.01%-2.70%-1.97%
1 Year Performance-71.43%-16.86%16.86%4.72%

Envoy Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COCH
Envoy Medical
2.3294 of 5 stars
$1.48
+1.4%
$9.13
+516.6%
-71.4%$31.56M$225,000.00-1.0534Analyst Revision
News Coverage
Gap Up
LUCD
Lucid Diagnostics
2.4826 of 5 stars
$1.20
-0.8%
$3.50
+191.7%
+94.7%$108.91M$4.35M-1.0570News Coverage
OBIO
Orchestra BioMed
2.5979 of 5 stars
$2.84
-0.4%
$15.00
+428.2%
-36.7%$108.81M$2.64M-1.764Analyst Forecast
News Coverage
Gap Down
AVR
Anteris Technologies Global
N/A$3.14
+9.0%
$16.50
+425.5%
N/A$103.57M$2.71M0.00138News Coverage
Positive News
INFU
InfuSystem
1.5023 of 5 stars
$4.91
flat
$13.00
+164.8%
N/A$103.19M$134.86M81.85410
KRMD
KORU Medical Systems
3.0593 of 5 stars
$2.24
-1.3%
$4.70
+109.8%
+12.8%$102.94M$33.65M-8.9680News Coverage
SKIN
Beauty Health
2.0237 of 5 stars
$0.82
-2.9%
$2.50
+204.4%
-69.4%$102.86M$334.29M-1.961,030
MGRM
Monogram Orthopaedics
2.4233 of 5 stars
$2.65
-1.9%
$5.40
+103.8%
+20.8%$93.52M$364,999.00-5.6428
ICAD
iCAD
0.5463 of 5 stars
$3.03
-5.9%
N/A+123.1%$82.92M$19.61M-23.31140Analyst Forecast
News Coverage
Gap Down
High Trading Volume
NSPR
InspireMD
2.1334 of 5 stars
$2.60
+0.4%
$4.75
+82.7%
+30.2%$79.65M$7.01M-3.4750Analyst Forecast
News Coverage
MBOT
Microbot Medical
1.8569 of 5 stars
$2.23
-10.4%
$9.00
+303.6%
+196.6%$77.48MN/A-2.7920News Coverage
Gap Up

Related Companies and Tools


This page (NASDAQ:COCH) was last updated on 4/27/2025 by MarketBeat.com Staff
From Our Partners